Quality & Speed

We take nothing for granted. The fact that a process works well does not mean that it works as well as it can.

At Boston Oncology, we deliver world-class drugs quickly and reliably by taking a blank slate approach to every aspect of pharmaceutical manufacturing, sales, and distribution.

Boston Oncology Product Enoxaparin

With the deep regional expertise of our leadership team, we bring a high degree of foresight to our product portfolio.  This, coupled with our intimate understanding of our customer’s needs and pain points, enables us to acquire and manage product licenses for what will be the most urgently needed and widely used therapeutics.

 

Able to pivot efficiently between products, and scale rapidly as demand changes
The optimal manufacturing process for every product, with 100% in-process controls

Our decades of experience with US, EU, and local regulatory processes provide the insight and creativity necessary to navigate regional approvals quickly and efficiently.  Wherever possible, we use the same documents for regional submissions that were used for the original USFDA / EMA submissions; and our local manufacturing operations often provide favorable access to accelerated regulatory consideration and approvals.

 

Boston Oncology products meet the highest quality standards. By creating state-of-the-art, modular, and highly flexible GMP-certified local manufacturing facilities, we are able to deploy the optimal manufacturing process for every product, with 100% in-process controls, pivot efficiently between products, and scale rapidly as demand changes. We also source API from the same batches manufactured for the US and European markets.

 

Boston Oncology Arabia Manufacturing Facility
Boston Oncology Arabia Manufacturing Facility
With our single-point-of-contact approach to procurement, customers always have a reliable and accountable partner close-at-hand, and are not required to coordinate with 3-5 points of contact throughout the purchasing journey. Finally, we own the supply chain – providing a high degree of control over the complex dependencies necessary to commercialize and deliver best-in-class generic and biosimilar therapeutic products.